Imvaria - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeImvaria
Imvaria logo

Imvaria

0 followers

About Imvaria

Imvaria is a health tech company focused on AI-driven digital biomarkers for pulmonology. Based in Berkeley, California, it develops non-invasive diagnostic and prognostic biomarkers to aid clinicians in diagnosing interstitial lung diseases and lung fibrosis earlier, while also partnering with biopharmaceuticals for trial optimization and biomarker discovery. The company emphasizes easy adoption through centralized services without heavy integration, and has produced FDA-authorized tools for IPF/ILD such as Fibresolve and ScreenDx. Through collaborations with academic and medical partners, Imvaria aims to improve patient outcomes by enhancing diagnostic accuracy and reducing the need for invasive biopsies.

Recent News

Recent Deals

Key Team Members

Carl-Erik Lagercrantz

CEO

Stefan Jansson

CEO of Polarium

Harald Mix

Chairman

Peter Carlsson

Co-founder of Northvolt

Paulo Cerutti

Co-founder of Northvolt

Key Facts

HQ Location

Berkeley, United States

Founded

2019

Employees

1 - 10

Status

Private

Website

https://imvaria.com